• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

GTX

Anonymous board for GTX
Replies
0
Views
470
anonymous
Replies
10
Views
3K
anonymous
Replies
2
Views
2K
anonymous
Replies
55
Views
25K
anonymous
Replies
2
Views
5K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
3
Views
5K
Anonymous
Replies
7
Views
7K
Anonymous
Replies
2
Views
5K
Anonymous
Replies
1
Views
5K
Anonymous
Replies
22
Views
9K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
5
Views
5K
Anonymous
Replies
2
Views
5K
Anonymous